DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Use of Ultrasonography to Determine Fluid-responsiveness for Shock in a Population of Intensive Care Unit Patients

Active, not recruiting

Conditions: Hypotension

First Posted Date: 2012-09-07

Last Posted Date: 2024-07-26

Lead Sponsor: University of Chicago

Target Recruit Count: 124

Registration Number: NCT01680770

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Pomalidomide
Drug: Carfilzomib
Drug: dexamethasone
Drug: Daratumumab

First Posted Date: 2012-08-15

Last Posted Date: 2024-11-19

Lead Sponsor: University of Chicago

Target Recruit Count: 101

Registration Number: NCT01665794

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
🇨🇦
University Health Network - Princess Margaret Cancer Center, Toronto, Ontario, Canada
🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

and more 2 locations

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Phase 1

Completed

Conditions: Adenocarcinoma of the Gallbladder
Adenocarcinoma of Unknown Primary
Adult Primary Cholangiocellular Carcinoma
Advanced Adult Primary Liver Cancer
Cholangiocarcinoma of the Extrahepatic Bile Duct
Acinar Cell Adenocarcinoma of the Pancreas
Cholangiocarcinoma of the Gallbladder
Diffuse Adenocarcinoma of the Stomach
Duct Cell Adenocarcinoma of the Pancreas
Intestinal Adenocarcinoma of the Stomach

Interventions: Drug: oxaliplatin
Drug: irinotecan hydrochloride
Drug: leucovorin calcium
Drug: fluorouracil
Other: laboratory biomarker analysis

First Posted Date: 2012-07-18

Last Posted Date: 2020-05-08

Lead Sponsor: University of Chicago

Target Recruit Count: 79

Registration Number: NCT01643499

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸
Evanston CCOP-NorthShore University HealthSystem, Evanston, Illinois, United States

Vitamin D Treatment in Ulcerative Colitis

Not Applicable

Withdrawn

Conditions: Ulcerative Colitis
Inflammatory Bowel Disease

Interventions: Other: Placebo
Drug: Vitamin D3

First Posted Date: 2012-07-13

Last Posted Date: 2014-12-02

Lead Sponsor: University of Chicago

Registration Number: NCT01640496

Locations: 🇺🇸
NorthShore, Evanston, Illinois, United States

Islet Transplantation in Patients With "Brittle" Type I Diabetes

Not Applicable

Recruiting

Conditions: Diabetes Mellitus, Type 1

Interventions: Biological: Allogenic islet cells (human, U. Chicago)
Procedure: Intraportal infusion of islet cells

First Posted Date: 2012-06-28

Last Posted Date: 2024-12-20

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT01630850

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Pain Assessment in the Intensive Care Unit

Completed

Conditions: Delirium
Critical Illness

Interventions: Procedure: Repositioning

First Posted Date: 2012-06-26

Last Posted Date: 2015-12-17

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT01628185

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections

Not Applicable

Terminated

Conditions: Abscess
Skin Diseases, Bacterial

Interventions: Biological: Linezolid
Biological: Clindamycin

First Posted Date: 2012-06-14

Last Posted Date: 2019-11-08

Lead Sponsor: University of Chicago

Target Recruit Count: 25

Registration Number: NCT01619410

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant

Not Applicable

Withdrawn

Conditions: Acute Kidney Injury
End Stage Kidney Disease
Liver Disease
Chronic Kidney Disease

Interventions: Procedure: Renal replacement therapy

First Posted Date: 2012-06-14

Last Posted Date: 2015-05-27

Lead Sponsor: University of Chicago

Registration Number: NCT01619449

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer

Phase 2

Completed

Conditions: Bone Metastases
Recurrent Prostate Cancer
Stage IV Prostate Cancer
Castrate-resistant Prostate Cancer

Interventions: Drug: cabozantinib
Other: laboratory biomarker analysis
Procedure: magnetic resonance imaging

First Posted Date: 2012-05-16

Last Posted Date: 2020-03-26

Lead Sponsor: University of Chicago

Target Recruit Count: 19

Registration Number: NCT01599793

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer

Not Applicable

Terminated

Conditions: Stage IV Renal Cell Cancer
Recurrent Renal Cell Cancer
Clear Cell Renal Cell Carcinoma

Interventions: Drug: pazopanib hydrochloride
Other: laboratory biomarker analysis
Procedure: dynamic contrast-enhanced magnetic resonance imaging
Other: pharmacogenomic studies

First Posted Date: 2012-05-16

Last Posted Date: 2017-06-08

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT01599832

Locations: 🇺🇸
Illinois Cancer Care (Peoria), Peoria, Illinois, United States
🇺🇸
Decatur Memorial Hospital, Decatur, Illinois, United States
🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy